March 7 (Reuters) - DORMAKABA HOLDING AG DOKA.S :
* H1 NET SALES OF CHF 1,419.8 MILLION (PREVIOUS YEAR: CHF
1,349.6
MILLION); GROWTH OF 5.2%
* H1 STRONG ORGANIC SALES GROWTH OF 8.0% (OF WHICH 6.5%
PRICING)
* H1 ADJUSTED EBITDA OF CHF 184.6 MILLION (PREVIOUS YEAR:
CHF
193.5 MILLION); ADJUSTED EBITDA MARGIN OF 13.0%, IN LINE WITH
GUIDANCE (PREVIOUS YEAR: 14.3%)
* H1 NET PROFIT OF CHF 84.9 MILLION (PREVIOUS YEAR: CHF
100.6
MILLION)
* H1 NET CASH FROM OPERATING ACTIVITIES OF CHF 103.9 MILLION
(PREVIOUS YEAR: CHF 49.3 MILLION); OPERATING CASH FLOW MARGIN OF
7.3%
* OUTLOOK FOR FULL 2022/23 FINANCIAL YEAR: DUE TO STRICTER
COST
MANAGEMENT, DORMAKABA EXPECTS SEQUENTIAL IMPROVEMENT TO SLIGHTLY
HIGHER ADJUSTED EBITDA MARGIN AND CONTINUED ORGANIC GROWTH ABOVE
ITS MID-TERM TARGET RANGE OF 3-5%
* BOARD OF DIRECTORS CONTINUES RENEWAL: RIET CADONAU TO
LEAVE
BOARD AT THE END OF APRIL 2023, HANDING OVER CHAIRMANSHIP TO
SVEIN RICHARD BRANDTZÆG
Further company coverage: DOKA.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))